Company attributes
Other attributes
Neuronetics, Inc. is a commercial-stage medical device company that focuses on designing, developing, and marketing products that improve the quality of life for patients that suffer from psychiatric disorders. It develops non-invasive treatment for chronic psychiatric, depression and neurological disorders using neuromodulation technology.
The company is the first company to have a non-systemic and non-invasive depression treatment that is cleared by the FDA for patients who haven't benefited from prior antidepressant treatment.
Neuronetics has NeuroStar® Advanced Therapy System, which is a leading transcranial magnetic stimulation (TMS) treatment for major depressive disorder and backed by the largest clinical data set of any TMS system.
The company designed NeuroStar as a non-invasive therapeutic alternative for treating patients who suffer from major depressive disorder and addressing many key limitations of the existing treatment options. NeuroStar therapy provides psychiatrist customers and their patients with several benefits.
